MB Financial Bank - Trust Department’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

MB Financial Bank - Trust Department’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-95	Closed	-$4K	–	660
2015 Q3	$4K	Hold	95	–	–	﹤0.01%	485
2015 Q2	$4K	Buy	+95	New	+$4.01K	﹤0.01%	483

Other funds holding WX

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CCS

Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

MB Financial Bank - Trust Department's WX Position: Q4 2015 in Review

MB Financial Bank - Trust Department sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 95 shares — an estimated $4K sold.

MB Financial Bank - Trust Department first reported a position in WX in Q2 2015 and held it in 2 quarters. The position peaked at $4K in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

MB Financial Bank - Trust Department reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
MB Financial Bank - Trust Department sold 95 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $4K.
MB Financial Bank - Trust Department first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2015 and held it in 2 quarters.
MB Financial Bank - Trust Department's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $4K in Q3 2015.
2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on MB Financial Bank - Trust Department's 13F filing for Q4 2015, filed 7 Jan 2016.